Abstract:Abstract Accurate predictions of druggability and bioactivities of compounds are desirable to reduce the high cost and time of drug discovery. After more than five decades of continuing developments, quantitative structure–activity relationship (QSAR) methods have been established as indispensable tools that facilitate fast, reliable and affordable assessments of physicochemical and biological properties of compounds in drug-discovery programs. Currently, there are mainly two types of QSAR methods, descriptor-based methods and graph-based methods. The former is developed based on predefined molecular descriptors, whereas the latter is developed based on simple atomic and bond information. In this study, we presented a simple but highly efficient modeling method by combining molecular graphs and molecular descriptors as the input of a modified graph neural network, called hyperbolic relational graph convolution network plus (HRGCN+). The evaluation results show that HRGCN+ achieves state-of-the-art performance on 11 drug-discovery-related datasets. We also explored the impact of the addition of traditional molecular descriptors on the predictions of graph-based methods, and found that the addition of molecular descriptors can indeed boost the predictive power of graph-based methods. The results also highlight the strong anti-noise capability of our method. In addition, our method provides a way to interpret models at both the atom and descriptor levels, which can help medicinal chemists extract hidden information from complex datasets. We also offer an HRGCN+'s online prediction service at https://quantum.tencent.com/hrgcn/.

Adaptive Configuring of Radial Basis Function Network by Hybrid Particle Swarm Algorithm for QSAR Studies of Organic Compounds.

Control Parameterization‐Based Adaptive Particle Swarm Approach for Solving Chemical Dynamic Optimization Problems

Back-Propagation Network Improved by Conjugate Gradient Based on Genetic Algorithm in Qsar Study on Endocrine Disrupting Chemicals

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

ChemInform Abstract: 3D QSAR Analyses of Novel Tyrosine Kinase Inhibitors Based on Pharmacophore Alignment.

ChemInform Abstract: Ordered Mesoporous Silica‐Based Inorganic Nanocomposites

ChemInform Abstract: Computational Methods for Design of Organic Materials with High Charge Mobility

Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method

ChemInform Abstract: QSAR Models Using a Large Diverse Set of Estrogens.

Comprehensive ensemble in QSAR prediction for drug discovery

ChemInform Abstract: Novel Approach to Structure‐Based Pharmacophore Search Using Computational Geometry and Shape Matching Techniques.

ChemInform Abstract: RASSE: A New Method for Structure‐Based Drug Design

Neural networks in QSAR studies: Estimation and prediction of biological activity for N-(substituted phenoxyethyl)-cyclopropylamines

Computer-Aided Molecular Design With Bp-Ann And Global Optimization Algorithm

QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models

Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery

QSAR Classification Modeling for Bioactivity of Molecular Structure via SPL-Logsum

ChemInform Abstract: Asymmetric Hydrogenation of Α‐hydroxy Ketones: A Reaction Sensitive Toward Electronic Effect of Substrates.

Organic Chemistry on Solid Surfaces

Cloud 3D-QSAR: a web tool for the development of quantitative structure–activity relationship models in drug discovery

ChemInform Abstract: Synthesis of New Schiff Base‐Camphorsulfonyl Amide Ligands and in Situ Screening in the Asymmetric Additions of Organozinc Reagents to Aldehydes.